| Basics |
Coherus BioSciences, Inc.
Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines.
|
| IPO Date: |
November 6, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$90.35M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.40 | 3.07%
|
| Avg Daily Range (30 D): |
$0.03 | 3.15%
|
| Avg Daily Range (90 D): |
$0.04 | 4.06%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.1M |
| Avg Daily Volume (30 D): |
1.39M |
| Avg Daily Volume (90 D): |
1.65M |
| Trade Size |
| Avg Trade Size (Sh.): |
151 |
| Avg Trade Size (Sh.) (30 D): |
329 |
| Avg Trade Size (Sh.) (90 D): |
335 |
| Institutional Trades |
| Total Inst.Trades: |
3,214 |
| Avg Inst. Trade: |
$1.51M |
| Avg Inst. Trade (30 D): |
$.69M |
| Avg Inst. Trade (90 D): |
$.69M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.76M |
| Avg Closing Trade (30 D): |
$2.58M |
| Avg Closing Trade (90 D): |
$2.58M |
| Avg Closing Volume: |
158.54K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.49
|
$-.44
|
$.25
|
|
Diluted EPS
|
$-.49
|
$-.4
|
$.25
|
|
Revenue
|
$ 7.6M
|
$ 54.14M
|
$ 266.96M
|
|
Gross Profit
|
$ 4.95M
|
$ 20.29M
|
$ 149.41M
|
|
Net Income / Loss
|
$ -56.57M
|
$ -50.7M
|
$ 28.51M
|
|
Operating Income / Loss
|
$ -45.44M
|
$ -42.25M
|
$ -111.67M
|
|
Cost of Revenue
|
$ 2.65M
|
$ 33.86M
|
$ 117.55M
|
|
Net Cash Flow
|
$ -43.58M
|
$ 28.3M
|
$ 22.91M
|
|
PE Ratio
|
|
|
|
|
